EW News and Press, Edwards Lifesciences Corporation From 10/25/19

Editor's Note: The summary bullets for this article were chosen by Seeking Alpha Read more ...

Are you worried about healthcare-sector stocks? Considering their performance lately, some nervousness is understandable. The S&P 500 index has climbed 9.8% higher over the past twelve months, but the iShares U.S. Healthcare ETF rose just 0.4% over the same period. Shares of health-rel...

Edwards Lifesciences Corp. (NYSE:EW) traded today at a new 52-week high of $236.73. This new high was reached on below average trading volume as 360,000 shares traded hands, while the average 30-day volume is approximately 909,000 shares. Edwards Lifesciences Corporation designs, develops, ma...

Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify (click the highlighted links). European stocks trade slightly higher as investors try to focus their attention away from the U.K. B...

Edwards Lifesciences   (NYSE: EW)  has been red-hot in 2019, breaking record highs on a routine basis . The company's transcatheter heart valve therapies (THVTs) continue to gain momentum in the marketplace.  But Edwards' sizzling streak was on the line when the company an...

Image source: The Motley Fool. Edwards Lifesciences Corp   (NYSE: EW) Q3 2019 Earnings Call Oct 23, 2019 , 5:00 p.m. ET Operator Continue reading

Edwards Lifesciences Corporation (EW) Q3 2019 Earnings Conference Call October 23, 2019 05:00 PM ET Company Participants Mark Wilterding - Vice President, Investor Relations Mike Mussallem - Chairman and Chief Executive Officer Scott Ullem - Chief Financial Officer Conference ...

Edwards Lifesciences (NYSE: EW ) Q3 result s: More news on: Edwards Lifesciences Corporation, Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...

Edwards Lifesciences (NYSE: EW ): Q3 Non-GAAP EPS of $1.41 beats by $0.19 ; GAAP EPS of $1.30 beats by $0.09 . Revenue of $1.1B (+21.3% Y/Y) beats by $60M . Shares +5.7% . Press Release More news on: Edwards Lifesciences Corporation, Earnings news and commentary, Stocks on the ...

IRVINE, Calif. , Oct. 23, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended September 30, 2019. ...